Back to GetFilings.com



Table of Contents

 
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 10-Q
 
(Mark One)
x
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
  For the Quarterly Period Ended May 31, 2002
 
¨
 
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
  For The Transition Period from                  to                 
 
Commission File Number: 0-11868
 

 
CARDIODYNAMICS INTERNATIONAL CORPORATION
(Exact name of registrant as specified in its charter)
 
California
 
95-3533362
(State or other jurisdiction
of incorporation or organization)
 
(IRS Employer
Identification No.)
 
6175 Nancy Ridge Drive, Suite 300, San Diego, California
 
92121
(Address of principal executive offices)
 
(Zip Code)
 
(858) 535-0202
(Registrant’s telephone number)
 

 
Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to fill such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  ¨
 
As of July 10, 2002, 46,144,712 shares of common stock and no shares of preferred stock were outstanding.
 


Table of Contents
 
CARDIODYNAMICS INTERNATIONAL CORPORATION
 
FORM 10-Q
 
TABLE OF CONTENTS
 
          
Page No.

PART I—FINANCIAL INFORMATION
 
      
Item 1.
 
 
Financial Statements:
      
   
 
    
3
   
 
    
4
   
 
    
5
   
 
    
6
Item 2.
 
 
    
9
Item 3.
 
 
    
17
PART II—OTHER INFORMATION
 
      
Item 1.
 
 
    
17
Item 2.
 
 
    
17
Item 3.
 
 
    
17
Item 4.
 
 
    
17
Item 5.
 
 
    
17
Item 6.
 
 
    
18
    
19

2


Table of Contents
 
PART I—FINANCIAL INFORMATION
 
Item 1.    Financial Statements
 
CARDIODYNAMICS INTERNATIONAL CORPORATION
 
BALANCE SHEETS
(In thousands, except share data)
 
ASSETS
  
May 31,
2002

    
November 30,
2001

 
    
(Unaudited)
    
(Audited)
 
Current assets:
                 
Cash and cash equivalents
  
$
6,405
 
  
$
6,394
 
Accounts receivable, net of allowance for doubtful accounts of $1,613 in 2002 and $1,425 in 2001
  
 
6,814
 
  
 
7,373
 
Inventory, net
  
 
3,541
 
  
 
2,821
 
Current portion of long-term receivables
  
 
2,086
 
  
 
1,663
 
Other current assets
  
 
455
 
  
 
431
 
    


  


Total current assets
  
 
19,301
 
  
 
18,682
 
Property and equipment, net
  
 
438
 
  
 
490
 
Long-term receivables and note receivable, net
  
 
2,051
 
  
 
2,259
 
Deposits
  
 
30
 
  
 
30
 
    


  


Total assets
  
$
21,820
 
  
$
21,461
 
    


  


LIABILITIES AND SHAREHOLDERS’ EQUITY
                 
Current liabilities:
                 
Accounts payable
  
$
1,450
 
  
$
1,338
 
Accrued expenses
  
 
340
 
  
 
277
 
Accrued salaries, wages and benefits
  
 
821
 
  
 
903
 
Current maturities of long-term debt
  
 
41
 
  
 
69
 
Deferred service revenue
  
 
401
 
  
 
411
 
    


  


Total current liabilities
  
 
3,053
 
  
 
2,998
 
Long-term debt, less current maturities
  
 
27
 
  
 
40
 
    


  


                   
Total liabilities
  
 
3,080
 
  
 
3,038
 
    


  


Shareholders’ equity:
                 
Preferred stock; no par value; 18,000,000 shares authorized; no shares issued or outstanding at May 31, 2002 or November 30, 2001
  
 
—  
 
  
 
—  
 
Common stock; no par value; 100,000,000 shares authorized; issued and outstanding 46,142,712 shares at May 31, 2002 and 45,798,322 shares at November 30, 2001
  
 
49,686
 
  
 
48,786
 
Accumulated deficit
  
 
(30,946
)
  
 
(30,363
)
    


  


Total shareholders’ equity
  
 
18,740
 
  
 
18,423
 
    


  


Commitments and contingencies
                 
Total liabilities and shareholders’ equity
  
$
21,820
 
  
$
21,461
 
    


  


 
 
See accompanying notes to financial statements.

3


Table of Contents
 
CARDIODYNAMICS INTERNATIONAL CORPORATION
 
STATEMENTS OF OPERATIONS
(Unaudited—In thousands, except share and per share data)
 
    
Three Months Ended May 31,

    
Six Months Ended May 31,

 
    
2002

    
2001

    
2002

    
2001

 
Net sales
  
$
5,623
 
  
$
4,480
 
  
$
9,989
 
  
$
8,445
 
Cost of sales
  
 
1,560
 
  
 
1,284
 
  
 
2,838
 
  
 
2,500
 
    


  


  


  


Gross margin
  
 
4,063
 
  
 
3,196
 
  
 
7,150
 
  
 
5,945
 
    


  


  


  


Operating expenses:
                                   
Research and development
  
 
611
 
  
 
902
 
  
 
1,253
 
  
 
1,713
 
Selling and marketing
  
 
3,049
 
  
 
2,470
 
  
 
5,770
 
  
 
4,663
 
General and administrative
  
 
422
 
  
 
396
 
  
 
861
 
  
 
846
 
    


  


  


  


Total operating expenses
  
 
4,082
 
  
 
3,768
 
  
 
7,884
 
  
 
7,222
 
    


  


  


  


Loss from operations
  
 
(19
)
  
 
(572
)
  
 
(734
)
  
 
(1,277
)
    


  


  


  


Other income (expense):
                                   
Interest income
  
 
76
 
  
 
164
 
  
 
182
 
  
 
355
 
Interest expense
  
 
(3
)
  
 
(16
)
  
 
(6
)
  
 
(29
)
Other, net
  
 
(6
)
  
 
(6
)
  
 
(24
)
  
 
(12
)
    


  


  


  


Total other income
  
 
67
 
  
 
142
 
  
 
152
 
  
 
314
 
    


  


  


  


Income (loss) before income taxes
  
 
48
 
  
 
(430
)
  
 
(582
)
  
 
(963
)
Income taxes
  
 
(1
)
  
 
—  
 
  
 
(1
)
  
 
(1
)
    


  


  


  


Net income (loss)
  
$
47
 
  
$
(430
)
  
$
(583
)
  
$
(964
)
    


  


  


  


Net income (loss) per share, basic and diluted
  
$
.00
 
  
$
(.01
)
  
$
(.01
)
  
$
(.02
)
    


  


  


  


Weighted-average number of common shares outstanding, basic
  
 
46,113,799
 
  
 
45,524,882
 
  
 
46,024,279
 
  
 
45,522,310
 
    


  


  


  


Weighted-average number of common shares outstanding, diluted
  
 
47,433,448
 
  
 
45,524,882
 
  
 
46,024,279
 
  
 
45,522,310
 
    


  


  


  


 
 
 
See accompanying notes to financial statements.

4


Table of Contents
 
CARDIODYNAMICS INTERNATIONAL CORPORATION
 
STATEMENTS OF CASH FLOWS
(Unaudited—In thousands)
 
    
Six Months Ended May 31,

 
    
2002

    
2001

 
Cash flows from operating activities:
                 
Net loss
  
$
(583
)
  
$
(964
)
Adjustments to reconcile net loss to net cash used in operating activities:
                 
Depreciation and amortization
  
 
144
 
  
 
139
 
Provision for warranty repairs
  
 
78
 
  
 
19
 
Provision for obsolete inventory
  
 
56
 
  
 
48
 
(Reduction in) provision for demonstration inventory
  
 
(16
)
  
 
45
 
Provision for (reduction in) doubtful receivables
  
 
188
 
  
 
(309
)
Provision for (reduction in) doubtful long-term receivables
  
 
25
 
  
 
(73
)
Compensatory stock options granted
  
 
36
 
  
 
31
 
Changes in operating assets and liabilities:
                 
Accounts receivable
  
 
371
 
  
 
(1,272
)
Inventory
  
 
(760
)
  
 
(540
)
Other current assets
  
 
(240
)
  
 
(837
)
Long-term receivables and note receivable
  
 
(24
)
  
 
51
 
Accounts payable
  
 
112
 
  
 
(461
)
Accrued expenses
  
 
(15
)
  
 
(361
)
Accrued salaries, wages and benefits
  
 
(82
)
  
 
(42
)
Deferred service revenue
  
 
(10
)
  
 
244
 
    


  


<